Comparative Biosciences, Inc. (CBI), a preclinical contract research organization (CRO), offers a complete program of preclinical research services in toxicology to support a range of assessments. Beginning with early assessment of new molecules including single dose, multiple dose, and targeted studies, as well as directed or investigative toxicology, and finishing with complete IND enabling toxicology programs, CBI provides expertise, attention, and care on every study. Our study directors are experienced, communicative, and attentive, and we produce high-quality GLP reports in a very timely fashion.
CBI provides expertise, attention, and care on toxicology research including early assessment of new molecules with single dose, multiple dose, and targeted studies; directed or investigative toxicology; and complete IND enabling toxicology programs.
CBI provides expertise in the following preclinical contract toxicology services: